Skip Nav Destination
Issues
15 August 2017
-
Cover Image
Cover Image
![issue cover]()
The cover shows a section of a mastectomy from a patient with a primary metaplastic breast carcinoma. This hematoxylin and eosin-stained section shows a component of the tumor with high-grade ductal differentiation. For details, see the article by Avigdor and colleagues on page 4875 of this issue.Close Modal - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Drug Updates
Molecular Pathways
Special Report
Clinical Trial Brief Report
Author Choice
Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial
Ann M. Mohrbacher; Allen S. Yang; Susan Groshen; Shivaani Kummar; Martin E. Gutierrez; Min H. Kang; Denice Tsao-Wei; C. Patrick Reynolds; Edward M. Newman; Barry J. Maurer
Cancer Therapy: Clinical
Phase I Trial of Intratumoral Injection of CCL21 Gene–Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration
Jay M. Lee; Mi-Heon Lee; Edward Garon; Jonathan W. Goldman; Ramin Salehi-Rad; Felicita E. Baratelli; Dörthe Schaue; Gerald Wang; Fran Rosen; Jane Yanagawa; Tonya C. Walser; Ying Lin; Stacy J. Park; Sharon Adams; Francesco M. Marincola; Paul C. Tumeh; Fereidoun Abtin; Robert Suh; Karen L. Reckamp; Gina Lee; William D. Wallace; Sarah Lee; Gang Zeng; David A. Elashoff; Sherven Sharma; Steven M. Dubinett
Intra- and Interobserver Reproducibility Assessment of PD-L1 Biomarker in Non–Small Cell Lung Cancer
Wendy A. Cooper; Prudence A. Russell; Maya Cherian; Edwina E. Duhig; David Godbolt; Peter J. Jessup; Christine Khoo; Connull Leslie; Annabelle Mahar; David F. Moffat; Vanathi Sivasubramaniam; Celine Faure; Alena Reznichenko; Amanda Grattan; Stephen B. Fox
Circulating DNA Demonstrates Convergent Evolution and Common Resistance Mechanisms during Treatment of Colorectal Cancer
Alain R. Thierry; Brice Pastor; Zhi-Qin Jiang; Anastasia D. Katsiampoura; Christine Parseghian; Jonathan M. Loree; Michael J. Overman; Cynthia Sanchez; Safia El Messaoudi; Marc Ychou; Scott Kopetz
Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer
Elahe A. Mostaghel; Eunpi Cho; Ailin Zhang; Mohammad Alyamani; Arja Kaipainen; Sean Green; Brett T. Marck; Nima Sharifi; Jonathan L. Wright; Roman Gulati; Lawrence D. True; Massimo Loda; Alvin M. Matsumoto; Daniel Tamae; Trevor N. Penning; Steven P. Balk; Phillip W. Kantoff; Peter S. Nelson; Mary-Ellen Taplin; R. Bruce Montgomery
Author Choice
PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer
Jian-Ming Xu; Yan Wang; You-Liang Wang; Tao Liu; Ming Ni; Man-Sheng Li; Li Lin; Fei-Jiao Ge; Chun Gong; Jun-Yan Gu; Ru Jia; He-Fei Wang; Yu-Ling Chen; Rong-Rui Liu; Chuan-Hua Zhao; Zhao-Li Tan; Yang Jin; Yun-Ping Zhu; Shuji Ogino; Zhi-Rong Qian
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors
Tessa Brabander; Wouter A. van der Zwan; Jaap J.M. Teunissen; Boen L.R. Kam; Richard A. Feelders; Wouter W. de Herder; Casper H.J. van Eijck; Gaston J.H. Franssen; Eric P. Krenning; Dik J. Kwekkeboom
Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study
Susumu Hijioka; Waki Hosoda; Keitaro Matsuo; Makoto Ueno; Masayuki Furukawa; Hideyuki Yoshitomi; Noritoshi Kobayashi; Masafumi Ikeda; Tetsuhide Ito; Shoji Nakamori; Hiroshi Ishii; Yuzo Kodama; Chigusa Morizane; Takuji Okusaka; Hiroaki Yanagimoto; Kenji Notohara; Hiroki Taguchi; Masayuki Kitano; Kei Yane; Hiroyuki Maguchi; Yoshiaki Tsuchiya; Izumi Komoto; Hiroki Tanaka; Akihito Tsuji; Syunpei Hashigo; Yoshiaki Kawaguchi; Tetsuya Mine; Atsushi Kanno; Go Murohisa; Katsuyuki Miyabe; Tadayuki Takagi; Nobutaka Matayoshi; Tsukasa Yoshida; Kazuo Hara; Masayuki Imamura; Junji Furuse; Yasushi Yatabe; Nobumasa Mizuno
Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma
Austin G. Duffy; Chi Ma; Susanna V. Ulahannan; Osama E. Rahma; Oxana Makarova-Rusher; Liang Cao; Yunkai Yu; David E. Kleiner; Jane Trepel; Min-Jung Lee; Yusuke Tomita; Seth M. Steinberg; Theo Heller; Baris Turkbey; Peter L. Choyke; Cody J. Peer; William D. Figg; Brad J. Wood; Tim F. Greten
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors
Carolyn D. Britten; Elizabeth Garrett-Mayer; Steven H. Chin; Keisuke Shirai; Besim Ogretmen; Tricia A. Bentz; Alan Brisendine; Kate Anderton; Susan L. Cusack; Lynn W. Maines; Yan Zhuang; Charles D. Smith; Melanie B. Thomas
Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial
Lee Shaashua; Maytal Shabat-Simon; Rita Haldar; Pini Matzner; Oded Zmora; Moshe Shabtai; Eran Sharon; Tanir Allweis; Iris Barshack; Lucile Hayman; Jesusa Arevalo; Jeffrey Ma; Maya Horowitz; Steven Cole; Shamgar Ben-Eliyahu
The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
Laxmi Silwal-Pandit; Silje Nord; Hedda von der Lippe Gythfeldt; Elen K. Møller; Thomas Fleischer; Einar Rødland; Marit Krohn; Elin Borgen; Øystein Garred; Tone Olsen; Phuong Vu; Helle Skjerven; Anne Fangberget; Marit M. Holmen; Ellen Schlitchting; Elisabeth Wille; Mette Nordberg Stokke; Hans Kristian Moen Vollan; Vessela Kristensen; Anita Langerød; Steinar Lundgren; Erik Wist; Bjørn Naume; Ole Christian Lingjærde; Anne-Lise Børresen-Dale; Olav Engebraaten
Personalized Medicine and Imaging
Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations
Adam A. Friedman; Yun Xia; Lorenzo Trippa; Long Phi Le; Vivien Igras; Dennie T. Frederick; Jennifer A. Wargo; Kenneth K. Tanabe; Donald P. Lawrence; Donna S. Neuberg; Keith T. Flaherty; David E. Fisher
Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of TP53 Missense Mutation in Prostate Cancer
Liana B. Guedes; Fawaz Almutairi; Michael C. Haffner; Gaurav Rajoria; Zach Liu; Szczepan Klimek; Roberto Zoino; Kasra Yousefi; Rajni Sharma; Angelo M. De Marzo; George J. Netto; William B. Isaacs; Ashley E. Ross; Edward M. Schaeffer; Tamara L. Lotan
Author Choice
Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance
Manish Kohli; Yeung Ho; David W. Hillman; Jamie L. Van Etten; Christine Henzler; Rendong Yang; Jamie M. Sperger; Yingming Li; Elizabeth Tseng; Ting Hon; Tyson Clark; Winston Tan; Rachel E. Carlson; Liguo Wang; Hugues Sicotte; Ho Thai; Rafael Jimenez; Haojie Huang; Peter T. Vedell; Bruce W. Eckloff; Jorge F. Quevedo; Henry C. Pitot; Brian A. Costello; Jin Jen; Eric D. Wieben; Kevin A.T. Silverstein; Joshua M. Lang; Liewei Wang; Scott M. Dehm
Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine
Hatim Husain; Vladislava O. Melnikova; Karena Kosco; Brian Woodward; Soham More; Sandeep C. Pingle; Elizabeth Weihe; Ben Ho Park; Muneesh Tewari; Mark G. Erlander; Ezra Cohen; Scott M. Lippman; Razelle Kurzrock
In Vivo Detection of EGFRvIII in Glioblastoma via Perfusion Magnetic Resonance Imaging Signature Consistent with Deep Peritumoral Infiltration: The ϕ-Index
Spyridon Bakas; Hamed Akbari; Jared Pisapia; Maria Martinez-Lage; Martin Rozycki; Saima Rathore; Nadia Dahmane; Donald M. O'Rourke; Christos Davatzikos
Cancer Therapy: Preclinical
Author Choice
Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER+ Breast Cancer Patient-derived Xenograft Models
Teeru Bihani; Hitisha K. Patel; Heike Arlt; Nianjun Tao; Hai Jiang; Jeffrey L. Brown; Dinesh M. Purandare; Gary Hattersley; Fiona Garner
Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition
Ola Rizq; Naoya Mimura; Motohiko Oshima; Atsunori Saraya; Shuhei Koide; Yuko Kato; Kazumasa Aoyama; Yaeko Nakajima-Takagi; Changshan Wang; Tetsuhiro Chiba; Anqi Ma; Jian Jin; Tohru Iseki; Chiaki Nakaseko; Atsushi Iwama
Biology of Human Tumors
Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma
Yuuki Iida; Aaron Ciechanover; Diego M. Marzese; Keisuke Hata; Matias Bustos; Shigeshi Ono; Jinhua Wang; Matthew P. Salomon; Kevin Tran; Stella Lam; Sandy Hsu; Nellie Nelson; Yelena Kravtsova-Ivantsiv; Gordon B. Mills; Michael A. Davies; Dave S.B. Hoon
Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
Sam L. Ivry; Jeremy M. Sharib; Dana A. Dominguez; Nilotpal Roy; Stacy E. Hatcher; Michele T. Yip-Schneider; C. Max Schmidt; Randall E. Brand; Walter G. Park; Matthias Hebrok; Grace E. Kim; Anthony J. O'Donoghue; Kimberly S. Kirkwood; Charles S. Craik
Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component
Bracha Erlanger Avigdor; Katie Beierl; Christopher D. Gocke; Daniel J. Zabransky; Karen Cravero; Kelly Kyker-Snowman; Berry Button; David Chu; Sarah Croessmann; Rory L. Cochran; Roisin M. Connolly; Ben H. Park; Sarah J. Wheelan; Ashley Cimino-Mathews
Author Choice
Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
Vassiliki Saloura; Aiman Fatima; Makda Zewde; Kazuma Kiyotani; Ryan Brisson; Jae-Hyun Park; Yuji Ikeda; Theodore Vougiouklakis; Riyue Bao; Arun Khattri; Tanguy Seiwert; Nicole Cipriani; Mark Lingen; Everett Vokes; Yusuke Nakamura
Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast Cancer
Mariaelena Pierobon; Corinne Ramos; Shukmei Wong; K. Alex Hodge; Jessica Aldrich; Sara Byron; Stephen P. Anthony; Nicholas J. Robert; Donald W. Northfelt; Mohammad Jahanzeb; Linda Vocila; Julia Wulfkuhle; Guido Gambara; Rosa I. Gallagher; Bryant Dunetz; Nicholas Hoke; Ting Dong; David W. Craig; Massimo Cristofanilli; Brian Leyland-Jones; Lance A. Liotta; Joyce A. O'Shaughnessy; John D. Carpten; Emanuel F. Petricoin
Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non–Small Cell Lung Cancer
Anna Li; Jin-ji Yang; Xu-chao Zhang; Zhou Zhang; Jian Su; Lan-ying Gou; Yu Bai; Qing Zhou; Zhenfan Yang; Han Han-Zhang; Wen-Zhao Zhong; Shannon Chuai; Qi Zhang; Zhi Xie; Hongfei Gao; Huajun Chen; Zhen Wang; Zheng Wang; Xue-ning Yang; Bin-chao Wang; Bin Gan; Zhi-hong Chen; Ben-yuan Jiang; Si-pei Wu; Si-yang Liu; Chong-rui Xu; Yi-long Wu
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison
Joel C. Sunshine; Peter L. Nguyen; Genevieve J. Kaunitz; Tricia R. Cottrell; Sneha Berry; Jessica Esandrio; Haiying Xu; Aleksandra Ogurtsova; Karen B. Bleich; Toby C. Cornish; Evan J. Lipson; Robert A. Anders; Janis M. Taube
Advertisement
